Arctoris To Overhaul Drug Discovery With Automation

Building a robotics infrastructure "is the only way to make sure we generate data of sufficient quality at the speed and scale required, and now everybody in the pharma industry is very excited about the idea of end-to-end automation." So says Martin-Immanuel Bittner, CEO of Arctoris.

innovation concept
• Source: Alamy

Back To Rising Leaders Gallery

Martin-Immanuel Bittner is a medical doctor and cancer researcher turned life sciences entrepreneur who as co-founder and CEO of Arctoris,...

More from C-Suite Speaks

More from Leadership